| Literature DB >> 29177050 |
Farzad Najafipour1, Majid Mobasseri2, Abbas Yavari3, Haidar Nadrian4,5, Akbar Aliasgarzadeh2, Naimeh Mashinchi Abbasi6, Mitra Niafar2, Jalil Houshyar Gharamaleki1, Vahideh Sadra2.
Abstract
OBJECTIVE: The effects of regular exercise on the health promotion of patients with type 2 diabetes mellitus (T2DM) have been well documented. The present study investigated the long-term effects of regular exercise training on biological indicators among these patients.Entities:
Keywords: A1c; Physical Exercise And Health
Year: 2017 PMID: 29177050 PMCID: PMC5687538 DOI: 10.1136/bmjdrc-2017-000414
Source DB: PubMed Journal: BMJ Open Diabetes Res Care ISSN: 2052-4897
Figure 1Study design and the participants’ dropout. T2DM, type 2 diabetes mellitus.
Descriptive statistics
| Group | Mean | SD | N | |
| Post-BMI | Experiment | 27.33 | 4.42 | 15 |
| Post-HBA1c | Experiment | 6.49 | 0.59 | 15 |
| Post-VO2max | Experiment | 31.92 | 7.59 | 15 |
Tests of between-subjects effects
| Source | Dependent variable | Mean square | F | P value | Partial Eta squared | Observed power |
| Group | Post-BMI | 103.08 | 17.15 | 0.00 | 0.40 | 0.97 |
| Error | Post-BMI | 6.010 |
BMI, body mass index; HbA1c, hemoglobin A1c.
Pairwise comparisons
| Dependent variable | (I) group | (J) group | Mean difference (I−J) | SE | P value |
| Post-BMI | Experiment | Control | −3.81* | 0.922 | 0.000 |
| Control | Experiment | 3.81* | 0.922 | 0.000 | |
| Post-HbA1c | Experiment | Control | −1.06* | 0.319 | 0.003 |
| Control | Experiment | 1.063* | 0.319 | 0.003 | |
| Post-VO2max | Experiment | Control | 12.97* | 1.28 | 0.000 |
| Control | Experiment | −12.97* | 1.28 | 0.000 |
*P<0.05.
BMI, body mass index; HbA1c, hemoglobin A1c.
Changes in BMI and HbA1c during the 8 years of study among patients with T2DM
| First analysis after 16 weeks | P value | Second analysis 52 weeks later | P value | Third analysis 4 years later | P value | Fourth analysis 2 years later | P value | |||
| BMI*, | Exp. | Before | 30.48 (3.52) | <0.0001 | 29.4 (5.7) | <0.0001 | 28 (5.2) | <0.001 | 29.17 (5.1) | <0.001 |
| After | 29.9 (3.55) | 28.2 (9.2) | 26.42 (4.36) | 27.33 (4.4) | ||||||
| Cont. | Before | 30.13 (3.35) | =0.740 | 30.14 (3.3) | <0.001 | 30.02 (4.79) | <0.01 | 29.42 (5.1) | <0.056 | |
| After | 30.18 (3.21) | 31.02 (5.1) | 31.05 (4.84) | 31.25 (1) | ||||||
| HbA1c, | Exp. | Before | 8.33 (1.29) | <0.001 | 8.48 (1.18) | <0.001 | 8.51 (2.1) | <0.001 | 8.33 (1.2) | <0.001 |
| After | 7.6 (1.04) | 7.15 (0.82) | 7.38 (4.8) | 6.49 (0.6) | ||||||
| Cont. | Before | 8.16 (1.26) | =0.673 | 7.97 (0.58) | =0.260 | 7.81 (1.8) | <0.01 | 7.78 (1.2) | =0.894 | |
| After | 8.44 (1.22) | 8.12 (2.1) | 7.83 (1.1) | 8.17 (0.98) | ||||||
*BMI, body mass index; M, mean; Exp., experiment group; Cont., control group.
Figure 2Timeline changes in BMI and HbA1c of the patients with T2DM during the 8 years of study. BMI, body mass index; Exp., experiment group; Cont., control group; HbA1c, hemoglobin A1c.